Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP)

Alicia K. Morgans; Alex Chehrazi-Raffle; Tamim Niazi; Neal D. Shore; Ashley E. Ross; Andreas Roder; Andrea Juliana Gomes; Stephane Supiot; Philippe Barthelemy; Koji Hatano; Carmen Belen Congregado Ruiz; Soichiro Yoshida; Bernardo Herrera-Imbroda; Matthieu Gratton; Jurgen E. Gschwend; Thomas A. Hope; Heikki Joensuu; Iris Kuss; Marie-Aude Le Berre; Miryana Dimova-Dobreva; Karim Fizazi

doi:10.1080/14796694.2025.2577633

Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP)

Alicia K. Morgans
, Alex Chehrazi-Raffle
, Tamim Niazi
, Neal D. Shore
, Ashley E. Ross
, Andreas Roder
, Andrea Juliana Gomes
, Stephane Supiot
, Philippe Barthelemy
, Koji Hatano
, Carmen Belen Congregado Ruiz
, Soichiro Yoshida
, Bernardo Herrera-Imbroda
, Matthieu Gratton
, Jurgen E. Gschwend
, Thomas A. Hope
, Heikki Joensuu
, Iris Kuss
, Marie-Aude Le Berre
, Miryana Dimova-Dobreva

Karim Fizazi

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	Future Oncology
Volume	21
Issue number	27
Pages (from-to)	3491-3498
Number of pages	8
ISSN	1479-6694
DOIs	https://doi.org/10.1080/14796694.2025.2577633
Publication status	Published - 14 Nov 2025
MoE publication type	A1 Journal article-refereed

Fields of Science

Darolutamide
Psma pet/ct
Biochemical recurrence
Cancer imaging
Prostate cancer
3122 Cancers

Access to Document

10.1080/14796694.2025.2577633

IFON_21_2577633Final published version, 3.43 MBLicence: CC BY-NC-ND

Cite this

Morgans, A. K., Chehrazi-Raffle, A., Niazi, T., Shore, N. D., Ross, A. E., Roder, A., Gomes, A. J., Supiot, S., Barthelemy, P., Hatano, K., Ruiz, C. B. C., Yoshida, S., Herrera-Imbroda, B., Gratton, M., Gschwend, J. E., Hope, T. A., Joensuu, H., Kuss, I., Le Berre, M.-A., ... Fizazi, K. (2025). Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP). Future Oncology, 21(27), 3491-3498. https://doi.org/10.1080/14796694.2025.2577633

@article{45368b4a13dc41288c37028b850acee4,

title = "Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP)",

keywords = "Darolutamide, Psma pet/ct, Biochemical recurrence, Cancer imaging, Prostate cancer, 3122 Cancers",

author = "Morgans, \{Alicia K.\} and Alex Chehrazi-Raffle and Tamim Niazi and Shore, \{Neal D.\} and Ross, \{Ashley E.\} and Andreas Roder and Gomes, \{Andrea Juliana\} and Stephane Supiot and Philippe Barthelemy and Koji Hatano and Ruiz, \{Carmen Belen Congregado\} and Soichiro Yoshida and Bernardo Herrera-Imbroda and Matthieu Gratton and Gschwend, \{Jurgen E.\} and Hope, \{Thomas A.\} and Heikki Joensuu and Iris Kuss and \{Le Berre\}, Marie-Aude and Miryana Dimova-Dobreva and Karim Fizazi",

year = "2025",

month = nov,

day = "14",

doi = "10.1080/14796694.2025.2577633",

language = "English",

volume = "21",

pages = "3491--3498",

journal = "Future Oncology",

issn = "1479-6694",

publisher = "Taylor and Francis Ltd.",

number = "27",

}

Morgans, AK, Chehrazi-Raffle, A, Niazi, T, Shore, ND, Ross, AE, Roder, A, Gomes, AJ, Supiot, S, Barthelemy, P, Hatano, K, Ruiz, CBC, Yoshida, S, Herrera-Imbroda, B, Gratton, M, Gschwend, JE, Hope, TA, Joensuu, H, Kuss, I, Le Berre, M-A, Dimova-Dobreva, M & Fizazi, K 2025, 'Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP)', Future Oncology, vol. 21, no. 27, pp. 3491-3498. https://doi.org/10.1080/14796694.2025.2577633

TY - JOUR

T1 - Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP)

AU - Morgans, Alicia K.

AU - Chehrazi-Raffle, Alex

AU - Niazi, Tamim

AU - Shore, Neal D.

AU - Ross, Ashley E.

AU - Roder, Andreas

AU - Gomes, Andrea Juliana

AU - Supiot, Stephane

AU - Barthelemy, Philippe

AU - Hatano, Koji

AU - Ruiz, Carmen Belen Congregado

AU - Yoshida, Soichiro

AU - Herrera-Imbroda, Bernardo

AU - Gratton, Matthieu

AU - Gschwend, Jurgen E.

AU - Hope, Thomas A.

AU - Joensuu, Heikki

AU - Kuss, Iris

AU - Le Berre, Marie-Aude

AU - Dimova-Dobreva, Miryana

AU - Fizazi, Karim

PY - 2025/11/14

Y1 - 2025/11/14

KW - Darolutamide

KW - Psma pet/ct

KW - Biochemical recurrence

KW - Cancer imaging

KW - Prostate cancer

KW - 3122 Cancers

U2 - 10.1080/14796694.2025.2577633

DO - 10.1080/14796694.2025.2577633

M3 - Article

C2 - 41216639

SN - 1479-6694

VL - 21

SP - 3491

EP - 3498

JO - Future Oncology

JF - Future Oncology

IS - 27

ER -